Jiang Su Yida Chemical Co Ltd
Jiang Su Yida Chemical Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.
Business. Jiang Su Yida Chemical Co Ltd (300721.SZ) is a Chinese chemical manufacturer operating within the commodity chemicals industry. The company is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Jiang Su Yida Chemical Co Ltd (300721.SZ) is a Chinese chemical manufacturer operating within the commodity chemicals industry. The company is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Jiang Su Yida Chemical Co Ltd has a market capitalization of 4.7 billion CNY and a price-to-earnings ratio of 611.75, indicating a high valuation relative to its earnings. The company's liquidity position is assessed as medium, with a current ratio of 0.54, suggesting that it has less than one CNY of current assets for every CNY of current liabilities. The debt-to-equity ratio of 0.84 indicates a moderate level of leverage, with long-term debt accounting for a significant portion of its capital structure.
The company's profitability is relatively low, with a return on equity of 0.63% and a return on assets of 0.3%, both of which are below the typical thresholds for healthy returns in the commodity chemicals industry. The operating margin is 1.45% (calculated as operating income of 6.85 million CNY divided by revenue of 470.72 million CNY), which is also below the median for the industry. The gross margin of 8.87% (calculated as gross profit of 41.78 million CNY divided by revenue of 470.72 million CNY) is similarly low, indicating that the company is facing significant cost pressures.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes in China. The company's operating cash flow of 68.71 million CNY is positive, but it is not sufficient to cover its capital expenditures of 45.02 million CNY, indicating that the company is reinvesting in its operations.
The company's growth trajectory is uncertain, with no specific revenue growth targets or projections provided in the available data. The company's high price-to-earnings ratio and low profitability suggest that it may be overvalued relative to its earnings potential. The company's capital expenditures are primarily directed toward maintaining and expanding its production capacity, which is a common practice in the commodity chemicals industry.
The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing. The company has not issued any new shares in the recent period, and there is no indication of dilution pressure in the near term.
The company has not disclosed any material recent events, such as new product launches, regulatory changes, or significant business developments, that would impact its financial performance or strategic direction. The company's financial statements do not indicate any material changes in its business operations or financial position in the most recent reporting period.
- The company has a high price-to-earnings ratio of 611.75, indicating a high valuation relative to its earnings.
- The company's profitability is low, with a return on equity of 0.63% and a return on assets of 0.3%.
- The company's liquidity position is medium, with a current ratio of 0.54.
- The company's revenue is concentrated in a single business segment, increasing its exposure to regional economic fluctuations.
- The company's capital expenditures are primarily directed toward maintaining and expanding its production capacity.
- The company has a low dilution risk, with no new shares issued in the recent period.
Bull / Bear case
Generated · model-assistedThe company generated CNY 1.6 billion in revenue in the latest period, demonstrating significant scale in the commodity chemicals sector.
Cash conversion metrics rank as best-in-class compared to the commodity chemicals cohort median, indicating superior operational efficiency.
Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value from share issuance.
The debt-to-equity ratio of 0.84 sits in the bottom quartile of the cohort, indicating excessive leverage.
Credit risk is flagged as high, raising concerns about the company's ability to meet its financial obligations.
Return on equity of 0.63% trails the cohort median of 3.61%, showing poor capital efficiency relative to peers.
In focus — financials by report
Revenue ¥1.55B, +7,2% YoY; Operating income −21,9% YoY.
- ▍Revenue ¥1.55B, +7,2% YoY
- ▍Operating income −21,9% YoY
- ▍Net income −16,9% YoY
- ▍Free cash flow +26,2% YoY
- ▍Net margin 7.1%
Revenue ¥1.45B; Operating income ¥161.9M.
- ▍Revenue ¥1.45B
- ▍Operating income ¥161.9M
- ▍Net margin 9.1%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Jiang Su Yida Chemical Co Ltd Market data — financials · 2026-05-26